Login to Your Account


Emerging markets
Despite strong economic and logistical arguments to be made for conducting clinical trials in Brazil, Russia, India and China (the BRIC countries), increasingly complex regulation, corruption and patent challenges are forcing drugmakers to up their game to succeed. more »

Opinion